Pages that link to "Q35892818"
Jump to navigation
Jump to search
The following pages link to Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis (Q35892818):
Displaying 31 items.
- Making Sense of: Sensitization in Schizophrenia (Q28077939) (← links)
- Targeting the dopamine D3 receptor: an overview of drug design strategies (Q34524556) (← links)
- Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists (Q34543859) (← links)
- Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system (Q35995415) (← links)
- Incubation of cocaine-craving relates to glutamate over-flow within ventromedial prefrontal cortex (Q36421854) (← links)
- Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D₂ and D₃ Receptors (Q36642828) (← links)
- Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity. (Q36803270) (← links)
- Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity (Q37025051) (← links)
- High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice. (Q37077658) (← links)
- Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region. (Q39252003) (← links)
- Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. (Q40955120) (← links)
- A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus (Q41444993) (← links)
- Effects of Acute and Chronic Treatments with Dopamine D2 and D3 Receptor Ligands on Cocaine versus Food Choice in Rats (Q45058435) (← links)
- Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors (Q46734392) (← links)
- Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores. (Q47416768) (← links)
- Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism (Q48116846) (← links)
- Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor (Q48145124) (← links)
- Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R). (Q48252285) (← links)
- Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs (Q49448169) (← links)
- Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior (Q51007789) (← links)
- Selectivity of probes for PET imaging of dopamine D3 receptors. (Q52316241) (← links)
- Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D receptor agonists (Q57143927) (← links)
- New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif (Q57822389) (← links)
- [--C]-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1-indole-2-carboxamide ([C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey (Q58576516) (← links)
- RETRACTED: Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors (Q61984897) (← links)
- Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats (Q90339007) (← links)
- Inclusion of enclosed hydration effects in the binding free energy estimation of dopamine D3 receptor complexes (Q90375092) (← links)
- Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects (Q90568986) (← links)
- Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders (Q92284092) (← links)
- Dopamine D3 Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats (Q93013726) (← links)
- Multimodal investigation of dopamine D2/D3 receptors, default mode network suppression, and cognitive control in cocaine-use disorder (Q100423058) (← links)